Postoperative radiotherapy in resected non-small cell lung cancer: The never-ending story

doi:10.5306/wjco.v12.i10.833

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 10

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5551)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

360

WORD

163

HTML

3592

Tables (1-3)

366

Sum=4481

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

379

Download

691

Sum=1070

Oct 24, 2021 (publication date) through Sep 19, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Evidence Review

World J Clin Oncol. Oct 24, 2021; 12(10): 833-844
Published online Oct 24, 2021. doi: 10.5306/wjco.v12.i10.833

Table 1 Recommendations for postoperative radiotherapy according to the main international guidelines

Guidelines	Clinical scenario	Recommendation for PORT
NCCN[9]	Stage pN0-1	Not recommended
	Stage pN2, negative surgical margins (R0)	Sequential
	Microscopic or macroscopic surgical margins (R1-R2)	Concomitant (selected cases) or sequential
ASTRO[10]	Stage pN2	Sequential
	Microscopic or macroscopic surgical margins (R1-R2)	Concomitant (selected cases) or sequential
	ESTRO-ASTRO[11]
	Multiple nodal stations involved	Sequential
	Extracapsular nodal extension	Sequential
ESMO[12]	Early stage (I-II) disease (R0)	Not recommended
	Positive margins or chest wall involvement (R1-R2)	Sequential
	Stage pN2	Only in selected cases
ASCO[13]	Early stage (I-II) disease (R0)	Not recommended
ASCO[13]	Stage pN2	Only in selected cases

NCCN: National Comprehensive Cancer Network; ASTRO: American Sociedad of Radiation Oncology; ESTRO: European Society for Radiotherapy & Oncology; ESMO: European Society for Medical Oncology; ASCO: American Society of Clinical Oncology; PORT: Postoperative radiotherapy.

Citation: Serrano J, Crespo PC, Taboada B, Gonzalez AA, García RG, Caamaño AG, Reyes JCT, Mielgo-Rubio X, Couñago F. Postoperative radiotherapy in resected non-small cell lung cancer: The never-ending story. World J Clin Oncol 2021; 12(10): 833-844
URL: https://www.wjgnet.com/2218-4333/full/v12/i10/833.htm
DOI: https://dx.doi.org/10.5306/wjco.v12.i10.833